Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID- 19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Autor: Rose, Angela M. C., Nicolay, Nathalie, Martín, Virginia Sandonis, Mazagatos, Clara, Petrović, Goranka, Baruch, Joaquin, Denayer, Sarah, Seyler, Lucie, Domegan, Lisa, Launay, Odile, Machado, Ausenda, Burgui, Cristina, Vaikutyte, Roberta, Niessen, F. Annabel, Loghin, Isabela I., Husa, Petr, Aouali, Nassera, Panagiotakopoulos, George, Tolksdorf, Kristin, Horváth, Judit Krisztina

Publikováno v: Eurosurveillance (15607917); 11/23/2023, Vol. 28 Issue 47, p1-17, 17p

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Autor: Rose AM; Epiconcept, Paris, France., Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden., Sandonis Martín V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Mazagatos C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Petrović G; Croatian Institute of Public Health, Zagreb, Croatia., Baruch J; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta., Denayer S; Sciensano, Brussels, Belgium., Seyler L; Universitair Ziekenhuis Brussel, Brussels, Belgium., Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Launay O; Inserm, CIC Cochin-Pasteur, Paris, France.; AP-HP, Hôpital Cochin, Paris, France.; Faculty of Medicine, University of Paris City, Paris, France., Machado A; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Burgui C; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Vaikutyte R; Lithuanian University of Health Sciences, Kaunas, Lithuania., Niessen FA; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Loghin II; St. Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.; Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania., Husa P; Faculty of Medicine, Masaryk University, Brno, Czechia.; University Hospital Brno, Brno, Czechia., Aouali N; Luxembourg Institute of Health, Luxembourg., Panagiotakopoulos G; National Public Health Organisation (EODY), Athens, Greece., Tolksdorf K; Robert Koch Institute, Berlin, Germany., Horváth JK; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Howard J; Epiconcept, Paris, France., Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Gallardo V; Dirección General de Salud Pública y Ordenación Farmacéutica, Junta de Andalucía, Spain., Nonković D; Teaching Public Health Institute of Split-Dalmatia County, Split, Croatia., Džiugytė A; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta., Bossuyt N; Sciensano, Brussels, Belgium., Demuyser T; Universitair Ziekenhuis Brussel, Brussels, Belgium., Duffy R; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Luong Nguyen LB; AP-HP, Hôpital Cochin, Paris, France., Kislaya I; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Martínez-Baz I; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Gefenaite G; Faculty of Medicine, Lund University, Lund, Sweden.; Lithuanian University of Health Sciences, Kaunas, Lithuania., Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Popescu C; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Součková L; University Hospital Brno, Brno, Czechia., Simon M; Centre Hospitalier de Luxembourg, Luxembourg., Michelaki S; National Public Health Organisation (EODY), Athens, Greece., Reiche J; Robert Koch Institute, Berlin, Germany., Ferenczi A; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Delgado-Sanz C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Lovrić Makarić Z; Croatian Institute of Public Health, Zagreb, Croatia., Cauchi JP; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta., Barbezange C; Sciensano, Brussels, Belgium., Van Nedervelde E; Universitair Ziekenhuis Brussel, Brussels, Belgium., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Durier C; Inserm, US19, Villejuif, Paris, France., Guiomar R; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Castilla J; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Jonikaite I; Lithuanian University of Health Sciences, Kaunas, Lithuania., Bruijning-Verhagen PC; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Lazar M; 'Cantacuzino' National Military Medical Institute for Research-Development, Bucharest, Romania., Demlová R; Faculty of Medicine, Masaryk University, Brno, Czechia., Wirtz G; Centre Hospitalier de Luxembourg, Luxembourg., Amerali M; National Public Health Organisation (EODY), Athens, Greece., Dürrwald R; Robert Koch Institute, Berlin, Germany., Kunstár MP; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Kissling E; Epiconcept, Paris, France., Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden., Valenciano M; Epiconcept, Paris, France.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Nov; Vol. 28 (47).